Serial Number | 79395760 |
Word Mark | SNIM |
Filing Date | Thursday, December 21, 2023 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Thursday, August 8, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceuticals; pharmaceutical drugs; dermatological pharmaceutical products; pharmaceutical preparations; dermatological pharmaceutical substances; pharmaceutical compositions; antidiabetic pharmaceuticals; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; injectable pharmaceuticals; tissue-regenerative pharmaceutical preparations; cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; anaesthetic preparations for inhalation; pharmaceutical preparations for inhalers; sanitary preparations and articles; hygienic preparations and articles; air deodorising and air purifying preparations; dental preparations; dental articles, namely materials for tooth restoration, dental cements, dental filling materials, bone fillers consisting of living materials as well as bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations; pest control preparations and articles; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compounds for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; autoantigens; vaccines; vaccine preparations; vaccine adjuvants; veterinary vaccines; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; antiviral drugs for treating influenza; vaccines for human use; fat emulsions for medical infusions; medical preparations; medicinal healthcare preparations; medicinal infusions; infusions (medicinal -); medicinal preparations and substances; medicine; serotherapeutic medicines; antiallergic medicines; medicines for animals; nucleic acid sequences for medical and veterinary purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; cellular function activating agents for medical purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; compounds for treating cancer; pharmaceutical preparations for activating cellular function; vaccines for cattle; vaccines for horses; veterinary vaccines for bovine animals; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the prevention of allergies; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the prevention of diseases caused by bacteria; pharmaceutical preparations for treating arthritis; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated creams for treating dermatological conditions; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances; bronchodilating preparations; organotherapeutic preparations; chemico-pharmaceutical preparations. |
Goods and Services | Preservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances for biological preparations regarding use in industry and science; biological preparations for use in industry and science; nucleic acids and organic chemicals for use in industry and science; industrial organic chemicals; organic chemicals for the industry; detergents for use in manufacture and industry; salts for industrial purposes; chemical and organic compositions for use in the manufacture of food and beverages; aqueous chemical compositions; triglycerides; nucleic recombinant acids; nucleic acids; nucleic acids for scientific purposes; pyrimidine; lipids for use in manufacture; hydrosoluble polymers; polymer dispersions; biodegradable polymer compositions; hydrogel polymer coatings; cationic polymers; polymer solutions; aqueous polymer dispersions; fatty acid esters. |
Goods and Services | Preparation and dispensing of medications; fertility treatment; human fertility treatment services; vaccination services; regenerative medicine services; dispensing of pharmaceuticals; therapy services; medical treatment services. |
Goods and Services | Research of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; vaccine research and development services; research and development services relating to vaccines; development of gene-based medicines; gene therapy research; research in the field of gene therapy; laboratory research in the field of gene expression; research in the field of gene editing technology; research and development services in the field of gene expression systems; advisory services relating to gene therapy research; biotechnology research; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; animal genetics research; research relating to molecular sciences; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research in the field of genetics; scientific research relating to genetics. |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 16, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 16, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 16, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 16, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Ethris GmbH |
Party Type | 10 - Original Applicant |
Legal Entity Type | 27 - NOT AVAILABLE |
Address | DE |
Event Date | Event Description |
Thursday, May 16, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, May 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, May 17, 2024 | APPLICATION FILING RECEIPT MAILED |
Monday, July 22, 2024 | ASSIGNED TO EXAMINER |
Tuesday, July 23, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, July 24, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, August 8, 2024 | REFUSAL PROCESSED BY MPU |
Thursday, August 8, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Sunday, August 25, 2024 | REFUSAL PROCESSED BY IB |